We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Poster: CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Authors
Cortes, Jorge E.; Hughes, Timothy P.; Mauro, Michael J.; Hochhaus, Andreas; Réa, Delphine; Yeow-Tee Goh; Janssen, J.J.W.M.; Heinrich, Michael C.; Talpaz, Moshe; Etienne, Gabriel; Breccia, Massimo; Deininger, Michael; le Coutre, Philipp; Lang, Fabian; Polydoros, Fotis; Cacciatore, Silvia; Stenson, Laura; Dong-Wook Kim
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2021, Vol 21, pS224
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/S2152-2650(21)01409-9